Retrophin

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge. What Happened: On Saturday, in a post on X, Shkreli forecasted a potential 90% drop in the shares of biotech startup, Inmune Bio Inc. (NASDAQ:...

Former hedge fund manager Martin Shkreli has issued a stark warning on the near-term trajectory of a biotech startup, just days after it witnessed a surge. What Happened: On Saturday, in a post on X, Shkreli forecasted a potential 90% drop in the shares of biotech startup, Inmune Bio Inc. (NASDAQ:...

From the slums of Shaolin, Wu-Tang Clan strikes again. An exclusive album made by the legendary hip-hop group is back in the news with the latest anonymous buyer of the album being revealed earlier this week. What Happened: The album “Once Upon a Time in Shaolin” was released as a two-...

After years of investigation and a six-week trial, "Pharma Bro" Martin Shkreli was found guilty on two counts of securities fraud and one count of conspiracy to commit securities fraud. The jury found him not guilty on five other charges after five days of deliberation. "We're...

Martin Shkreli, the so-called "most hated man on the Internet" is making news again. Retrophin Inc (NASDAQ: RTRX), a bio-pharmaceutical company that focuses on therapies for the treatment of rare diseases, saw its shares surge Wednesday. The company announced positive results from a...

The most unpopular man in the pharmaceutical world is in a little bit of trouble. Turing Pharmaceuticals founder Martin Shkreli has been arrested on securities fraud related to a firm he founded, Bloomberg reported Thursday morning. Separately, Reuters citing witness said the entrepreneur...